Home » FDA, Guided Therapeutics Unveil Plan for Rejected LuViva Cervical Scanner PMA
FDA, Guided Therapeutics Unveil Plan for Rejected LuViva Cervical Scanner PMA
Guided Therapeutics made new progress on its once-rejected pre-market approval bid for the LuViva advanced cervical cancer scanning system, which the FDA knocked with a “not approvable” letter in January.
Mass Device
Mass Device
Upcoming Events
-
07May
-
14May
-
23May
-
30May
-
21Oct